Follow
Ahmed E. Goda, PhD
Ahmed E. Goda, PhD
Professor, Faculty of Pharmacy, Tanta University,
Verified email at pharm.tanta.edu.eg - Homepage
Title
Cited by
Cited by
Year
Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis
T Yoshida, M Konishi, M Horinaka, T Yasuda, AE Goda, H Taniguchi, ...
Biochemical and Biophysical Research Communications 375 (1), 129-133, 2008
1892008
Baicalein overcomes tumor necrosis factor–related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells
H Taniguchi, T Yoshida, M Horinaka, T Yasuda, AE Goda, M Konishi, ...
Cancer research 68 (21), 8918-8927, 2008
1292008
The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?
WM Awara, AE El-Sisi, ME El-Sayad, AE Goda
Pharmacological research 50 (5), 487-498, 2004
912004
Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice
YA Haggag, MA Osman, SA El-Gizawy, AE Goda, MM Shamloula, ...
Biomedicine & Pharmacotherapy 105, 215-224, 2018
582018
Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor–related apoptosis-inducing ligand
T Yasuda, T Yoshida, AE Goda, M Horinaka, K Yano, T Shiraishi, ...
Molecular Cancer Research 6 (12), 1852-1860, 2008
482008
Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole
AE Goda, T Yoshida, M Horinaka, T Yasuda, T Shiraishi, M Wakada, ...
Oncogene 27 (24), 3435-3445, 2008
432008
Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules
H Taniguchi, M Horinaka, T Yoshida, K Yano, AE Goda, S Yasuda, ...
Molecular cancer therapeutics 11 (10), 2294-2300, 2012
422012
Molecular mechanisms of the antitumor activity of SB225002: a novel microtubule inhibitor
AE Goda, M Koyama, Y Sowa, KM Elokely, T Yoshida, BY Kim, T Sakai
Biochemical pharmacology 85 (12), 1741-1752, 2013
322013
Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis
M Koyama, Y Izutani, AE Goda, T Matsui, M Horinaka, M Tomosugi, ...
Clinical Cancer Research 16 (8), 2320-2332, 2010
322010
Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells
K Yano, M Horinaka, T Yoshida, T Yasuda, H Taniguchi, AE Goda, ...
International journal of oncology 38 (2), 365-374, 2011
282011
Lipoxygenase inhibitors induce death receptor 5/TRAIL‐R2 expression and sensitize malignant tumor cells to TRAIL‐induced apoptosis
T Yoshida, T Shiraishi, M Horinaka, S Nakata, T Yasuda, AE Goda, ...
Cancer science 98 (9), 1417-1423, 2007
262007
Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin
ND Fayed, AE Goda, EA Essa, GM El Maghraby
Journal of drug delivery science and technology 66, 102866, 2021
232021
The plausible mechanisms of tramadol for treatment of COVID-19
NE El-Ashmawy, AHA Lashin, KM Okasha, AMA Kamer, TM Mostafa, ...
Medical Hypotheses 146, 110468, 2021
212021
Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies
AE Goda, RL Erikson, T Sakai, JS Ahn, BY Kim
Molecular Oncology 9 (1), 309-322, 2015
212015
Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis
MF Saleh, ME Elsayad, AE Goda
Eur Rev Med Pharmacol Sci 25 (21), 6573-6584, 2021
122021
Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis
AE Goda, AM Elenany, AE Elsisi
Life Sciences 283, 119849, 2021
112021
Enhanced in vivo targeting of estrogen receptor alpha signaling in murine mammary adenocarcinoma by nilotinib/rosuvastatin novel combination
AE Goda, AE Elsisi, SS Sokkar, NM Abdelrazik
Toxicology and Applied Pharmacology 404, 115185, 2020
92020
Induction of G1 arrest by SB265610 involves cyclin D3 down-regulation and suppression of CDK2 (Thr160) phosphorylation
AE Goda, RL Erikson, JS Ahn, BY Kim
Anticancer research 35 (6), 3235-3243, 2015
52015
Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis
M Koyama, Y Sowa, M Horinaka, AE Goda, J Fujiwara, T Sakai
Oncology Reports 31 (2), 947-954, 2014
52014
Molecular insights into the microtubules depolymerizing activity of the IL-8 receptor B antagonist SB225002.
AE Goda, T Sakai
European Review for Medical & Pharmacological Sciences 26 (10), 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20